Babesiosis due to Babesia microti
ICD-10 B60.01 is a billable code used to indicate a diagnosis of babesiosis due to babesia microti.
Babesiosis is a malaria-like parasitic disease caused by protozoa of the genus Babesia, with Babesia microti being the most common species affecting humans in the United States. The disease is primarily transmitted through the bite of infected Ixodes scapularis ticks, commonly known as deer ticks. Clinical manifestations of babesiosis can range from asymptomatic to severe illness, particularly in immunocompromised individuals or those without a spleen. Symptoms typically include fever, chills, sweats, headache, body aches, loss of appetite, nausea, and fatigue. Laboratory findings may reveal hemolytic anemia, thrombocytopenia, and elevated liver enzymes. Diagnosis is confirmed through blood smear examination or serological tests. Treatment usually involves the use of antimalarial medications such as atovaquone combined with azithromycin or clindamycin combined with quinine. Prompt diagnosis and treatment are crucial to prevent complications such as respiratory failure, renal failure, and even death in severe cases.
Detailed clinical history, laboratory results, and treatment plans.
Patients presenting with fever and recent tick exposure.
Ensure all laboratory tests are documented to support diagnosis.
Comprehensive patient history and symptomatology.
Patients with flu-like symptoms after outdoor activities in endemic areas.
Documenting travel history and potential exposure to ticks.
Used when confirming a diagnosis of babesiosis through molecular testing.
Document the reason for testing and the clinical symptoms leading to the test.
Infectious disease specialists should ensure comprehensive documentation of the patient's history.
Common symptoms include fever, chills, sweats, headache, body aches, loss of appetite, nausea, and fatigue. Severe cases may lead to complications such as hemolytic anemia.
